This week’s Research Ethics Roundup covers President Trump’s call for removing a majority of FDA regulations, the argument for calling for efficacy data before human research begins, USDA’s decision to remove Animal Welfare Act records, and FDA’s case for conducting phase three testing. Read more
by Elisa A. Hurley, PhD, Education Director
The portrayal of research in popular media can offer considerable insight. To reflect on some of the lessons offered, PRIM&R staff have spent the summer reading and watching books, movies, and television shows that have generated conversation and debate around issues related to research ethics. Over the next several weeks, they will share their reflections here, so join us as [...] Read more
It’s back to school and back to work! Get into the swing of things by catching up on the latest news in the research ethics world (which never goes on vacation)!
Aveo Reeling after FDA's Rejection of Kidney Cancer Drug: Aveo Pharmaceuticals spent seven years and $300 million developing tivozanib, a kidney cancer drug, which was recently rejected by the [...] Read more
by Maeve Luthin, JD, Project Coordinator
It’s your favorite time of the week again! Take a few minutes to catch up with the research ethics world by reading through this edition of our Research Ethics Roundup.
US Regulator Plans to Declare Research Chimps Endangered: The US Fish and Wildlife Service Read more
by Maeve Luthin, JD, Project Coordinator
It’s been a busy two weeks in the research ethics world! Grab some iced coffee and take some time to catch up with current events.
Dirty Medicine: Earlier this month, generic drug manufacturer Ranbaxy pled guilty to federal criminal charges of selling adulterated drugs with the [...] Read more
